BioXcel Therapeutics Net Profit Margin Growth & History (BTAI)
BioXcel Therapeutics's net profit margin was −10,887.38% for fiscal 2025.
View full BioXcel Therapeutics company overviewBioXcel Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −10,887.38% | −8257.24 pp |
| 2024 | 2024-12-31 | −2,630.14% | +10344.71 pp |
| 2023 | 2023-12-31 | −12,974.86% | +31227.01 pp |
| 2022 | 2022-12-31 | −44,201.87% | — |
BioXcel Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −8,084.07% | +7905.10 pp |
| Q1 2026 | 2026-03-31 | −6,160.68% | −1842.82 pp |
| Q4 2025 | 2025-12-31 | −4,900.39% | −1933.45 pp |
| Q3 2025 | 2025-09-30 | −31,541.84% | −25163.33 pp |
| Q2 2025 | 2025-06-30 | −15,989.17% | −15237.45 pp |
| Q1 2025 | 2025-03-31 | −4,317.86% | +285.41 pp |
| Q4 2024 | 2024-12-31 | −2,966.94% | +2952.21 pp |
| Q3 2024 | 2024-09-30 | −6,378.50% | +8426.77 pp |
| Q2 2024 | 2024-06-30 | −751.72% | +10958.34 pp |
| Q1 2024 | 2024-03-31 | −4,603.26% | +21025.86 pp |
| Q4 2023 | 2023-12-31 | −5,919.15% | — |
| Q3 2023 | 2023-09-30 | −14,805.28% | +15709.32 pp |
| Q2 2023 | 2023-06-30 | −11,710.07% | — |
| Q1 2023 | 2023-03-31 | −25,629.13% | — |
| Q3 2022 | 2022-09-30 | −30,514.60% | — |
BioXcel Therapeutics net profit margin trends
Between the periods ended 2022-12-31 and 2025-12-31, BioXcel Therapeutics's net profit margin increased from −44,201.87% to −10,887.38%, a change of +33314.48 percentage points. The latest reported quarter, Q2 2026, shows −8,084.07%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioXcel Therapeutics source filings ↗